Today: 7 February 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Stock Price and Market Performance (Oct. 17 Update) Alibaba’s stock is capping off a strong week, with a notable move on October 17, 2025. The NYSE-listed BABA shares closed around $167 on Friday, recovering from early-session weakness. This roughly 3% intraday rebound came despite a sell-off in Hong Kong, where Alibaba’s secondary listing fell over 4% amid broad tech declines. Even with recent volatility, Alibaba’s U.S. stock remains near multi-year highs – up about 85–90% year-to-datets2.tech. By comparison, the NYSE Composite index is only up ~12% in 2025ts2.tech, underscoring Alibaba’s outsized rally. The stock’s momentum since spring carried it above
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: – Oscar Health (NYSE: OSCR) shares have surged in early October 2025, recently trading around $21–22 (up ~40% YTD)ts2.techmarketbeat.com. The stock hit about $21.50 on Oct 3 (+11% on the day) and was trading near $21.76 on Oct 14 (+6.7%)ts2.techmarketbeat.com. – Oscar announced a $410 million convertible debt offering in September 2025 to fund AI-driven technology and growth initiativests2.tech. Proceeds will back “strategic initiatives focused on AI” and expansion of member servicesbusinesswire.comts2.tech. – The company also forged a major partnership with Midwestern grocer Hy‑Vee: launching “Hy‑Vee Health with Oscar”, an employer health plan in Iowa. CEO Mark Bertolini
17 October 2025
·
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Stock Volatility and Recent Moves Reddit’s stock has been highly volatile. After its monster summer rally, RDDT pulled back sharply in early October. In mid-September 2025 it briefly hit a $282.95 recordts2.tech, but profit-taking and tech-sector jitters drove it back toward the $190s by Oct 17. On Oct 17, midday trading saw RDDT around $190.44, roughly 4.3% lower for the daystockanalysis.com. (By 1:57 p.m. it was about $192.14stockanalysis.com.) Year-to-date the stock is still up roughly 244%ts2.tech, far outperforming the S&P 500 and Nasdaq indices. Since the March 2024 IPO, RDDT is up more than six-fold (600%+)ts2.techreuters.com – a blistering return
17 October 2025
SoundHound AI Stock Skyrockets 240% – Is the Voice AI Boom Just Beginning?

SoundHound AI Stock Slides 10% After CFO Cashes In – Can the 240% AI Rally Survive?

Stock Slides After CFO’s Share Sale SoundHound AI stock sank on Friday after news of insider selling, undercutting some of the recent euphoria. The company’s Chief Financial Officer, Nitesh Sharan, disclosed he sold 60,376 SoundHound shares at an average ~$21.21 (a ~$1.28 million transaction)indexbox.io. The sale, executed under a pre-arranged 10b5-1 trading plan, reduced the CFO’s direct stake by about 3.3%indexbox.io. The market reacted swiftly: SOUN fell ~6.9% in morning trading on Oct. 17 following the disclosure, and by afternoon it was trading around $18.80, roughly 9–10% below the prior day’s closeindexbox.ioindexbox.io. The timing of Sharan’s sale coincided with a broader
17 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Stock Jumps as Outlook Brightens Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share Benzinga. Year-to-date, the stock has rallied nearly 47%, adding tens of billions to Gilead’s market value Stockanalysis. This far outpaces the single-digit gain of the Nasdaq Biotechnology Index over the same period Stockanalysis Invesco. Investors have cheered a string of positive catalysts: strong earnings, a fortified HIV franchise, and growing pipeline prospects. Notably, Gilead’s Q2 results in August beat expectations and prompted management to raise
17 October 2025
··
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Stock Performance & Recent Moves: Rekor stock has surged lately on a combination of upbeat corporate news and broader tech buzz. After closing around $2.60 on Oct. 16, REKR jumped roughly 20% on Oct. 17 (trading near $3.17)tradingview.com. This continued a steep one-month rally: TS2.tech notes the shares have climbed about 73% in the past 30 daysts2.tech. This meteoric rise came as the company previewed blowout third-quarter results and rolled out new contracts. Wall Street observers say the valuation – now about 5.8× sales – appears “fair” relative to peers given Rekor’s growth outlookts2.tech. (By comparison, Rekor grew revenue ~7%
17 October 2025
·
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Stock Performance: From Slump to Sudden Surge ts2.techLiberty Energy’s stock has seen a dramatic swing in recent weeks. After grinding lower for most of 2025 – at one point down over 40% year-to-date – LBRT caught a bid in October, climbing roughly 15% during the monthts2.tech. The rally accelerated on October 17 when the company’s latest earnings sparked a burst of buying. Intraday, LBRT shares jumped into the mid-$15 range, marking a one-day gain of more than 20%. Even with that pop, Liberty’s stock is a far cry from where it started the year (above $20). The one-year total return
17 October 2025
···
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

In sum, the mid-October “crypto Black Friday” crash has ignited a firestorm of questions about market manipulation and the fragility of trading infrastructure. Evidence of suspicious whale trades, exchange glitches, and perfectly-timed exploits suggest that the rout may have been at least partly orchestrated, rather than a natural response to bad news. Regulators are under pressure to scrutinize what really happened behind the scenes. The crypto market, meanwhile, is gingerly finding its footing again. Bitcoin’s price is well off its highs but signs of resilience – from hodlers doubling down to institutional money staying put – offer hope that the
17 October 2025
·
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Stock Price Skyrockets on Acquisition News Shares of XORTX Therapeutics Inc. (NASDAQ: XRTX) surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per share (up from around $0.86 the prior day)ragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level. This rally was accompanied by an explosion in
17 October 2025
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

FDA Setback Triggers Strategic Review Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to reach alignment with the U.S. Food and Drug Administration on the design of a pivotal trial for zetomipzomib in autoimmune hepatitis (AIH)ca.investing.com. The FDA abruptly canceled a Type C meeting that was scheduled for Q4 2025 to discuss Kezar’s proposed Phase 3 trial, and instead requested a new standalone study to characterize zetomipzomib’s pharmacokinetics in patients with severe liver impairmentstocktitan.netstocktitan.net. The
17 October 2025
·
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

FDA Voucher Ignites IRON Stock Rally Disc Medicine’s stock price (NASDAQ: IRON) spiked dramatically in mid-October 2025 after news of the FDA voucher, vaulting from the mid-$70s to the low-$90s in a single daygurufocus.com. On Friday (Oct. 17), IRON opened around $85 and surged to an intraday high of $92.50 before closing at $93.00, marking a ~25% jump on the daystockanalysis.com. This leap capped a steady uptrend over the past month – the shares were trading near $60 in early September and gradually climbed into the $70s as anticipation built around bitopertin’s NDA filing and reviewstockanalysis.comstockanalysis.com. The FDA’s award of
17 October 2025
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Stock’s Wild 2025 Ride – From $14 to $130+ 🚀 Nebius Group’s logo on display – the AI cloud upstart has seen its stock skyrocket in 2025 amid major deals. Few stocks captured the AI frenzy of 2025 like Nebius Group. This Amsterdam-headquartered cloud upstart – born from the breakup of Russia’s Yandex – has seen its Nasdaq-listed shares soar by triple digits. Year-to-date, NBIS has climbed roughly +350%, far outpacing broader tech indicests2.tech. The stock hit an all-time high around $132-$135 in early October, a stunning jump from just ~$14 a year agots2.tech. As one analysis noted, Nebius’
17 October 2025
··
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Bumpy Ride for CRM Stock in 2025 Salesforce’s stock (NYSE: CRM) has been on a rollercoaster in recent weeks. After a steep September sell-off – when cautious guidance sent shares to multi-month lows around $235ts2.tech – the stock found a footing in the mid-$230s. Heading into mid-October, CRM began to stabilize. On October 16, shares surged about 4% after Salesforce issued a surprisingly strong long-term forecast, lifting the stock to roughly $246 by Thursday’s closereuters.com. That rebound comes as a relief to investors: even after the pop, CRM remains down roughly 27–29% year-to-datereuters.com, a stark contrast to major indexes. In
17 October 2025
·
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt Stock Skyrockets 22% After Earnings Shock – Can the Rally Hold?

J.B. Hunt’s corporate headquarters in Lowell, Arkansas. The trucking giant delivered an earnings surprise that sent its stock soaring. Stock Rockets on Earnings Beat J.B. Hunt’s stock exploded higher after the company’s third-quarter results blew past expectations. Shares surged from about $139 (Wednesday’s close) to $169.57 by Thursday’s close, a 22.1% one-day leapfinviz.com. Investors haven’t seen a move like that in years – the best single-day gain in decades for J.B. Hunt’s stock, according to market watchers. The price spike came on unusually heavy trading volume (6.5 million shares traded vs. an average of ~1–2 million), reflecting intense interest from
17 October 2025
·
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets on Gold Boom: Record Highs, $100 B Milestone & Bold Forecasts

Newmont Shares Soar to Multi-Year Highs Newmont’s stock price has been on a tear, skyrocketing this week to levels not seen in years. Shares traded around the high-$90s on October 17 – up sharply from the low-$80s just a week ago – after rallying ~14.8% from last Friday to Thursday’s close alonefinviz.com. The stock hit a fresh 52-week high near $98.58 on Thursdayfinviz.com, and in doing so Newmont’s market cap crossed the $100 billion threshold for the first timeboerse-am-sonntag.de. This milestone is significant: Newmont is now on the cusp of becoming the first-ever gold mining company valued in twelve digits, reflecting
17 October 2025
·
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Soars on Failed Sabadell Takeover Bid – Analysts See Upside Ahead

BBVA Shares Jump as Takeover Bid Collapses Madrid, October 17, 2025 – Banco Bilbao Vizcaya Argentaria (BBVA) stock jumped sharply on Friday after the Spanish banking giant’s hostile bid for Banco Sabadell fell through. BBVA shares rose about 5–7% in Madrid trading, closing near €16.8 (up roughly 6.9% on the day)investing.comreuters.com, while Sabadell’s stock plunged over 6%reuters.com. The rally came as BBVA announced it would immediately restart share buybacks – buying back €1 billion of its own shares starting October 31 – now that the Sabadell deal is off the tablets2.tech. BBVA also declared its largest-ever interim dividend of €0.32 per
17 October 2025
·
Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell’s Bold $2 Billion Bet and Oil Price Twist: What’s Next for Shell Stock?

Shell Stock Climbs Amid Market Volatility Shell plc’s stock price held firm on Friday at around £26.72 per share, capping off a choppy week on a positive note. The shares inched up ~0.2% on the dayhl.co.uk – a notable rebound after slipping earlier when global markets sold off. Over the past few sessions, Shell’s price oscillated between roughly £26.3 and £26.8 as investors digested oil price swings and company newsreuters.com. Despite this volatility, Shell’s stock gained roughly 3–4% on the weekhl.co.uk, outpacing the broader FTSE 100 which fell to two-week lows amid banking and commodity weaknessreuters.com. Traders say resilient oil
17 October 2025
·
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds Stock Nears Decade High as Bank Shrugs Off £2bn Scandal Hit

Market Rally Puts Lloyds Near Record Levels Lloyds Banking Group (LON: LLOY) stock is flirting with decade highs after an impressive 2025 rally. Shares in the UK’s largest retail bank traded around 85 pence on 17 October – roughly unchanged from Thursday’s close – having recovered from a sharp fall earlier in the daysharesmagazine.co.uk. In morning trade, Lloyds tumbled nearly 3% to about 82p amid a broad sell-off in financials, as fears over U.S. regional bank loan troubles rattled global marketsreuters.com. By afternoon, however, Lloyds had clawed back those losses, reflecting its relative strength in a volatile session. The FTSE
17 October 2025
·
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

GRAIL (GRAL) Rockets to Record High on Samsung Mega-Deal and Cancer Test Breakthrough

Samsung Partnership Sparks Stock Surge GRAIL, Inc. (NASDAQ: GRAL) shares soared to record highs this week after the company announced a strategic collaboration with Samsung. On October 16, GRAIL revealed a binding agreement in which Samsung C&T and Samsung Electronics will invest $110 million into GRAIL at $70.05 per sharets2.tech. In return, Samsung C&T gains exclusive rights to distribute GRAIL’s Galleri multi-cancer early detection blood test in South Korea, with plans to expand to Japan and Singaporets2.tech. Samsung Electronics will explore technology tie-ups, integrating its digital health platforms and AI with GRAIL’s cancer-detection technologytradingview.comprnewswire.com. Investors cheered the deal as a major
17 October 2025
·
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Stock Skyrockets to Record High – Will It Climb Higher or Run Out of Fuel?

Stock Price Soars to Multi-Year High Rolls-Royce’s stock has been on fire in 2025. The share price has climbed ~124% over the past 12 months, far outpacing the broader marketts2.tech. After languishing below £1 in 2020’s crisis, the stock took flight as global air travel rebounded and defence spending surged. By late September this year, Rolls-Royce shares hit approximately 1,196p, which TS2.tech notes is a multi-year (and effectively all-time) high for the companyts2.tech. This remarkable rally – about +100% year-to-date – has elevated Rolls-Royce into the top tier of London-listed companies, with a market capitalization near £99–100 billionts2.tech. It’s now among
17 October 2025
1 … 221 222 223 224 225 … 352

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
New York, Feb 7, 2026, 09:30 EST — Market closed. Applied Digital Corporation shares closed up 25.52% on Friday at $34.95, after trading between $29.24 and $35.09 on the session. The stock was down about 1% in after-hours trading at around $34.60, according to delayed quotes. (Applied Digital Corporation) The surge puts the Nasdaq-listed data center operator back in focus heading into Monday, after a week in which investors started looking beyond the crowded “tech and AI” trade. “What’s driven it recently has been the broadening in the market beyond just the tech, AI trade,” said Chuck Carlson, chief executive
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop